CD274 and neoplasm: However, the disadvantages of this bispecific antibodies with anti-PD-1 or anti-PD-L1 arms may exist: (1) inaccurate drug targeting and easy to produce off target effect (2) the drug may have the same ADCC toxic effect on T cells induced by natural kill (NK) cells as tumor cells.